Basics |
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$373.9B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.68 | 0.64%
|
Avg Daily Range (30 D): |
$1.03 | 0.67%
|
Avg Daily Range (90 D): |
$1.41 | 0.90%
|
Institutional Daily Volume |
Avg Daily Volume: |
8M |
Avg Daily Volume (30 D): |
5.56M |
Avg Daily Volume (90 D): |
6.87M |
Trade Size |
Avg Trade Size (Sh.): |
143 |
Avg Trade Size (Sh.) (30 D): |
56 |
Avg Trade Size (Sh.) (90 D): |
59 |
Institutional Trades |
Total Inst.Trades: |
151,364 |
Avg Inst. Trade: |
$8.03M |
Avg Inst. Trade (30 D): |
$23.51M |
Avg Inst. Trade (90 D): |
$22.01M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
27 |
Market Closing Trades |
Avg Closing Trade: |
$126.38M |
Avg Closing Trade (30 D): |
$248.83M |
Avg Closing Trade (90 D): |
$250.44M |
Avg Closing Volume: |
979.07K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$9.06
|
$4.57
|
$1.42
|
Diluted EPS
|
$8.99
|
$4.54
|
$1.41
|
Revenue
|
$ 89.33B
|
$ 21.89B
|
$ 22.52B
|
Gross Profit
|
$ 61.01B
|
$ 14.54B
|
$ 15.39B
|
Net Income / Loss
|
$ 21.81B
|
$ 11B
|
$ 3.43B
|
Operating Income / Loss
|
$ 26.6B
|
$ 13.63B
|
$ 3.89B
|
Cost of Revenue
|
$ 28.32B
|
$ 7.36B
|
$ 7.13B
|
Net Cash Flow
|
$ 13B
|
$ 14.37B
|
$ 4.13B
|
PE Ratio
|
17.28
|
|
|
|
|
|